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Research
Correspondence Carotid Intima-Medial Thickness in National FootballLeague Players as an Index of Cardiovascular Disease RiskTo the Editor: The cardiovascular disease risk of professional
football players has been questioned with regard to their
increasing size, which reflects trends in the general population.
Although a study of retired players by the National Institute of
Occupational Safety and Health found that their age-adjusted
death rate was 46% lower than that of the general population,
cardiovascular disease mortality was increased 6-fold in the
largest players compared with the smallest players (1). We
previously published a survey of National Football League
(NFL) players, which found that players had higher blood
pressure, similar lipid levels, and lower fasting glucose and
smoking rates than an age-matched nonathletic cohort (2). As
part of the original study, we measured carotid intima-media
hickness (CIMT) as an integrated index of cardiovascular risk.
Of the 504 subjects in the overall study, CIMT was measured
n 124 players on 3 teams during minicamps held April to June
007. Informed consent and institutional review board approval
MedStar Health Research Institute, Washington, DC) were
btained, and the NFL Subcommittee on Cardiovascular
ealth oversaw the study. Player positions were divided into
inemen (offensive centers, guards, and tackles, and defensive
ackles and ends) and nonlinemen (tight ends, long snappers,
nd all other players).
Ultrasound studies were performed using an ultrasound
ervice (Ultrasound Services Inc., Newtown, Pennsylvania)
ertified by the Intersocietal Commission for the Accreditation
f Echocardiography Laboratories, and results were analyzed at
emple University Medical Center (Philadelphia, Pennsylva-
ia). CIMT measurements were conducted on the far field wall
f the right common carotid artery using the Esaote IMT LAB
Anthropometric and Cardiovascular Characteristics AcTable 1 Anthropometric and Cardiovascular Chara
Characteristic
Linemen
(n  50)
Age (yrs) 27.6 (26.7–28.5)
Height (in) 76.3 (75.7–76.8)
Weight (lb) 311 (303–318)
BMI (kg/m2) 37.6 (36.6–38.5)
Body fat (%) 24.2 (22.4–25.8)
HDL (mg/dl) 46 (42–50)
LDL (mg/dl) 118 (110–127)
Total cholesterol (mg/dl) 179 (170–189)
Triglycerides (mg/dl) 93 (81–106)
Glucose (mg/dl) 85 (83–88)
SBP (mm Hg) 131 (128–133)
DBP (mm Hg) 79 (77–81)
IMT (mm) 0.65 (0.63–0.68)
RCCA diameter (mm) 6.78 (6.64–6.91)
Values are mean (95% confidence interval).
BMI  body mass index; DBP  diastolic blood pressure; HDL  high-de
lipoprotein; RCCA  right common carotid artery; SBP  systolic blood pressVersion 2.0 software program (Esaote North America, India-
napolis, Indiana). Three repeat measurements from R-wave
gated optimal frames were obtained using the leading edge
method, and the results were averaged. Common carotid
diameters were also obtained on the right common carotid
artery 1 cm proximal to the bifurcation.
Anthropometric and cardiovascular data divided according to
player position are shown in Table 1. The overall mean CIMT
was 0.63 mm (95% confidence interval: 0.62 to 0.65) and was
higher in linemen than in nonlinemen (0.65 mm vs. 0.62 mm;
p  0.014). We identified a modest association between CIMT
and some parameters of body size, including body mass index
(r  0.29; p  0.001), weight (r  0.21; p  0.020), and waist
circumference (r  0.18; p  0.049). CIMT was not correlated
with other traditional cardiovascular risk factors such as percent
body fat, waist to hip ratio, and blood pressure. Mean CIMT
was 0.65 mm in black players and 0.61 mm in white players
(p  0.056). Carotid diameter was larger in linemen, but CIMT
did not correlate with diameter. No plaque was found in any
studies.
To place the CIMT values of our population in context,
previous reports on CIMT in age-equivalent men were identi-
fied. Mean values ranged from 0.47 mm to 0.71 mm. Some
populations studied had noticeable differences from ours in risk
factors. The Atherosclerosis Risk Factors in Male Youngsters
study of 17- to 18-year-old white men characterized by high
smoking rates demonstrated a mean CIMT of 0.47 mm (3).
The Atherosclerosis Risk in Young Adults study and the
Muscatine Study populations were most similar in age to the
NFL players (4,5), with mean CIMTs of 0.49 mm and 0.52 mm,
g to Player Position Type and Overalltics According to Player Position Type and Overall
onlinemen
(n  74) All p Value
5 (26.8–28.3) 27.5 (27.0–28.1) 0.918
5 (72.0–73.2) 74.0 (73.5–74.6) 0.001
8 (213–224) 255 (247–265) 0.001
1 (28.5–29.7) 32.5 (31.6–33.4) 0.001
0 (11.9–14.0) 17.5 (16.2–18.9) 0.001
0 (48–52) 48 (46–50) 0.004
5 (105–124) 116 (110–123) 0.474
7 (179–196) 184 (177–190) 0.369
6 (82–112) 95 (86–105) 0.781
6 (83–89) 86 (84–88) 0.405
5 (122–127) 127 (125–129) 0.005
5 (73–77) 77 (75–78) 0.009
2 (0.60–0.64) 0.63 (0.62–0.65) 0.014
8 (6.27–6.50) 6.55 (6.45–6.64) 0.001cordincteris
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February 14, 2012:699–701respectively. An age-extrapolated CIMT value of 0.51 mm was
found in the Atherosclerosis Risk in Communities study investi-
gating 40- to 60-year-old subjects (6). The Cardiovascular Risk in
Young Finns Study of slightly older men than our NFL group (24
to 39 years of age) revealed a mean CIMT of 0.64 mm (7). In this
study, CIMT was significantly correlated with body mass index,
systolic blood pressure, low-density lipoprotein levels, and smok-
ing. The Bogalusa Heart Study, also of older subjects (25 to 39
years of age), found mean CIMT to be 0.67 mm in whites and 0.71
mm in blacks (8). Although the CIMT value we found in the NFL
populations was near the higher end of the published range, precise
comparison was not possible.
There are several limitations to our study. The study cohort may be
too small to adequately identify all correlates of CIMT. It would be
most helpful to have a comparison population better matched for age
and cardiovascular risk factors. It would be beneficial to obtain
measurements at more than one time during and after their career.
In active NFL players, CIMT correlates with some parameters of
size (body mass index, weight, and waist circumference) but not with
other traditional cardiovascular risk factors. CIMT values from studies
most similar in age were found to be generally lower than our
population. A possible link between large body size and cardiovascular
risk may exist independent of traditional risk factors.
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Study. J Am Coll Cardiol 2005;46:457–63.Letters to the EditorCoronary Computed Tomography
Angiography Versus Coronary
Calcium Computed Tomography for
Prognosis With Regard to Mortality
Min et al. (1) present important information on a large database of
individuals undergoing coronary computed tomography angiogra-
phy (CCTA) with regard to the significance of coronary stenosis as
a predictor of future mortality. This study demonstrates the
prognostic significance of coronary stenosis as assessed by CCTA
in predicting future mortality.
There is another important question that this data set has the potential
to answer. Does the number of vessels with significant coronary stenosis
present have prognostic significance in terms ofmortality beyond a simple
measure of total coronary artery plaque as assessed by coronary arteryA key question for any diagnostic tool to be added to the
armamentarium of available tests for the purpose of assessing
mortality is whether the new test performs better than less
expensive test modalities, particularly if there is a less expensive
diagnostic test with slightly less risk.
Coronary calcium CT is much less expensive and uses approx-
imately one-tenth of the radiation of CCTA (2). It is important
therefore to demonstrate an improvement over this less-costly
modality, which imparts considerably less radiation, when the goal
is to predict prognosis regarding mortality.
Would the authors re-examine their data for stratification of
these same patients according to coronary calcium results with
regard to mortality prognosis? Because CCTA, in many cases, is
performed with a coronary calcium CT at the onset of the test, this
information is potentially available.
In the dataset of the paper, 42.5% of the patients were
normal, 34.0% were found to have nonobstructive coronary
artery disease (CAD), 13.1% had 1-vessel CAD, and 10.4%
